Page 182 - medicina-integrativa_compress
P. 182

CAPÍTULO 16  ESCLEROSIS MÚLTIPLE      175

             25.  Mishra LC, Singh BB, Dagenais S: Scientific basis for the   lymphocytes in patients with systemic lupus erythematosus (SLE).
                therapeutic use of Withania somnifera (ashwagandha): A review.  Clin Exp Immunol 99:251-255, 1995.
                Altern Med Rev 5:334-346, 2000.                 32.  Petajan JH, White AT: Recommendations for physical activity in
             26.  Panda S, Kar A: Evidence for free radical scavenging activity of  patients with MS. Sports Med 27:179-191, 1999.
                ashwagandha root powder in mice. Indian J Physiol Pharmacol  33.  Sutherland G, Andersen M: Exercise and multiple sclerosis:
                41:424-426, 1997.                                   Physiological, psychological, and quality of life issues. J Sports Med
             27.  Yoshikawa T, Naito Y, Kondo M: Gingko biloba leaf extract:   Phys Fitness 41:421-432, 2001.
                Review of biological actions and clinical applications. Antioxid  34.  Using Yoga to help with multiple sclerosis
                Redox Signal 1:469, 1999.                           (www.americanyogaassociation.org.)
             28.  Soldan SS, Alvarez, Retuerto AI, et al: Immune modulation in  35.  Barnes D, Hughes RAC, Morris R, et al: Randomized trial of oral
                multiple sclerosis patients treated with the pregnancy hormone  and intravenous methylprednisolone in acute relapses of multiple
                estriol. J Immunol 171:6267-6274, 2003.             sclerosis. Lancet 349:285-294, 1997.
             29.  Voskuhl RR: Gender issues and multiple sclerosis. Curr Neurol  36.  Frohman EM, Stuve O, Havrdova E, et al: Therapeutic
                Neurosci Rep 2:277-286, 2002.                       considerations for disease progression in multiple sclerosis. Arch
             30.  Voskuhl RR, Palaszynski K: Sex hormones in experimental  Neur 62:1519-1530, 2005.
                autoimmune encephalomyelitis: Implications for multiple   37.  Panitch H, Miller A, Paty D, Weinshenker B, North American
                sclerosis. Neuroscientist 7:258-270, 2001.          Study Group on Interferon beta and secondary progressive
             31.  Suzuki T, Suzuki N, Engleman EG, et al: Low serum levels of  MS: Interferon beta-1b in secondary progressive MS: Results
                dehydroepiandrosterone may cause deficient IL-2 production by  from a 3-year controlled study. Neurology 63:1788-1795, 2004.




































           © Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
   177   178   179   180   181   182   183   184   185   186   187